首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   997篇
  免费   112篇
  国内免费   1篇
  2022年   14篇
  2021年   18篇
  2020年   9篇
  2019年   10篇
  2018年   13篇
  2017年   10篇
  2016年   18篇
  2015年   28篇
  2014年   28篇
  2013年   41篇
  2012年   58篇
  2011年   54篇
  2010年   27篇
  2009年   34篇
  2008年   55篇
  2007年   39篇
  2006年   35篇
  2005年   44篇
  2004年   36篇
  2003年   43篇
  2002年   30篇
  2001年   30篇
  2000年   25篇
  1999年   26篇
  1998年   11篇
  1997年   10篇
  1996年   17篇
  1995年   8篇
  1994年   19篇
  1993年   12篇
  1992年   17篇
  1991年   13篇
  1990年   12篇
  1989年   18篇
  1988年   14篇
  1987年   16篇
  1986年   18篇
  1985年   14篇
  1984年   13篇
  1983年   11篇
  1982年   11篇
  1981年   6篇
  1980年   9篇
  1979年   11篇
  1978年   11篇
  1977年   10篇
  1976年   13篇
  1975年   7篇
  1972年   6篇
  1967年   5篇
排序方式: 共有1110条查询结果,搜索用时 31 毫秒
101.
The effect of different starting stances from a standing position on short sprint times and the subsequent variability in times was investigated in this study. A dual-beam timing light system was used to measure 5- and 10-m times for 3 different standing starts commonly found in the sporting environment: parallel (feet parallel to the start line), split (lead left foot on start line, right leg back), and false (initial parallel start, right leg drops back to split start when movement initiated). The parallel start was found to be significantly (alpha < 0.05) slower than the other 2 stances for both the 5- ( approximately 8.3%) and the 10-m (approximately 5.9%) distances. Within the trial, variation of the different starting stances was equally consistent; however, there was less variability for the 10-m distance (CV = 1.16-1.67%) than the 5-m distance (CV = 1.43-2.15%) for each start for both men and women. The split and false start seem to offer the best option as a movement strategy for minimizing short-distance sprint times. However, the benefits of these 2 starts are less clear if total movement time is the variable of interest.  相似文献   
102.
103.
104.
105.
106.
Acute 7-day toxicity tests evaluating adverse effects from contact and ingestion exposure to light brown apple moth (LBAM) pheromones and time-released microencapsulated LBAM pheromones in CheckMate® LBAM-F (Checkmate) were conducted on newly emerged honeybees (less than 24 h old). Contact studies exposed bees to 1× and 10× the CheckMate label application rate. Ingestion studies exposed bees to CheckMate formulations, and active (pheromone) ingredients (a.i.) at 0.1%, 1.0%, and 10% concentrations by weight in solid food. Bees ingested approximately 39% of their body weight during the tests. Mortality ranged from 2–10% in three of four contact and ingestion exposure trials. Trial 1, which utilized a different feeding design, showed higher mortality in both control and test replicates (9–28%). One-way ANOVA tests indicated no significant difference in mortality between control and treatment replicates in the four trials. Bees were subjected to one-time CheckMate contact exposures of up to 0.49 mg/kg-bee, and average pheromone and formulation ingestion exposures of up to 56 (0.1%), 611 (1.0%), and 6,282 (10%) mg/kg-bee-day. LBAM pheromones and microencapsulated pheromones proved to be non-toxic to honeybees when sprayed with 10× the field application rate, or when ingested in food at concentrations of up to 10% by weight.  相似文献   
107.
Increased susceptibility to the protease inhibitors saquinavir and amprenavir has been observed in human immunodeficiency virus type 1 (HIV-1) with specific mutations in protease (V82T and N88S). Increased susceptibility to ritonavir has also been described in some viruses from antiretroviral agent-naive patients with primary HIV-1 infection in association with combinations of amino acid changes at polymorphic sites in the protease. Many of the viruses displaying increased susceptibility to protease inhibitors also had low replication capacity. In this retrospective study, we analyze the drug susceptibility phenotype and the replication capacity of virus isolates obtained at the peaks of viremia during five consecutive structured treatment interruptions in 12 chronically HIV-1-infected patients. Ten out of 12 patients had at least one sample with protease inhibitor hypersusceptibility (change 相似文献   
108.
109.
The ratio of nonsynonymous (dN) to synonymous (dS) substitution rates, omega, provides a measure of selection at the protein level. Models have been developed that allow omega to vary among lineages. However, these models require the lineages in which differential selection has acted to be specified a priori. We propose a genetic algorithm approach to assign lineages in a phylogeny to a fixed number of different classes of omega, thus allowing variable selection pressure without a priori specification of particular lineages. This approach can identify models with a better fit than a single-ratio model, and with fits that are better than (in an information theoretic sense) a fully local model, in which all lineages are assumed to evolve under different values of omega, but with far fewer parameters. By averaging over models which explain the data reasonably well, we can assess the robustness of our conclusions to uncertainty in model estimation. Our approach can also be used to compare results from models in which branch classes are specified a priori with a wide range of credible models. We illustrate our methods on primate lysozyme sequences and compare them with previous methods applied to the same data sets.  相似文献   
110.
Isolation of well-preserved pure cell populations is a prerequisite for sound studies of the molecular basis of any tissue-based biological phenomenon. This article reviews current methods for obtaining anatomically specific signals from molecules isolated from tissues, a basic requirement for productive linking of phenotype and genotype. The quality of samples isolated from tissue and used for molecular analysis is often glossed over or omitted from publications, making interpretation and replication of data difficult or impossible. Fortunately, recently developed techniques allow life scientists to better document and control the quality of samples used for a given assay, creating a foundation for improvement in this area. Tissue processing for molecular studies usually involves some or all of the following steps: tissue collection, gross dissection/identification, fixation, processing/embedding, storage/archiving, sectioning, staining, microdissection/annotation, and pure analyte labeling/identification and quantification. We provide a detailed comparison of some current tissue microdissection technologies, and provide detailed example protocols for tissue component handling upstream and downstream from microdissection. We also discuss some of the physical and chemical issues related to optimal tissue processing, and include methods specific to cytology specimens. We encourage each laboratory to use these as a starting point for optimization of their overall process of moving from collected tissue to high quality, appropriately anatomically tagged scientific results. In optimized protocols is a source of inefficiency in current life science research. Improvement in this area will significantly increase life science quality and productivity. The article is divided into introduction, materials, protocols, and notes sections. Because many protocols are covered in each of these sections, information relating to a single protocol is not contiguous. To get the greatest benefit from this article, readers are advised to read through the entire article first, identify protocols appropriate to their laboratory for each step in their workflow, and then reread entries in each section pertaining to each of these single protocols.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号